WDR76 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.050400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.918000E-01
Normal-vs-Stage2
6.881000E-01
Normal-vs-Stage3
3.488600E-01
Normal-vs-Stage4
5.579200E-01
Stage1-vs-Stage2
5.698200E-01
Stage1-vs-Stage3
4.774200E-01
Stage1-vs-Stage4
8.681000E-01
Stage2-vs-Stage3
2.150600E-01
Stage2-vs-Stage4
5.066800E-01
Stage3-vs-Stage4
5.414000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.739200E-01
Normal-vs-AfricanAmerican
7.096000E-01
Normal-vs-Asian
5.441600E-01
Caucasian-vs-AfricanAmerican
6.878000E-01
Caucasian-vs-Asian
1.460170E-01
AfricanAmerican-vs-Asian
3.878000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.170600E-01
Normal-vs-Female
8.303400E-01
Male-vs-Female
4.850100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.519800E-01
Normal-vs-Age(41-60Yrs)
8.561400E-01
Normal-vs-Age(61-80Yrs)
5.182000E-01
Normal-vs-Age(81-100Yrs)
7.528200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.452390E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.987410E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.156640E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.432220E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.916200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.610200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.942000E-01
Normal-vs-Daily Drinker
6.159600E-01
Normal-vs-Weekly Drinker
9.358200E-01
Normal-vs-Occasional Drinker
6.748000E-01
Normal-vs-Social Drinker
5.804800E-01
Non Drinker-vs-Daily Drinker
8.253400E-01
Non Drinker-vs-Weekly Drinker
6.220800E-01
Non Drinker-vs-Occasional Drinker
9.806400E-01
Non Drinker-vs-Social Drinker
7.115800E-01
Daily Drinker-vs-Weekly Drinker
5.261000E-01
Daily Drinker-vs-Occasional Drinker
8.106200E-01
Daily Drinker-vs-Social Drinker
8.613800E-01
Weekly Drinker-vs-Occasional Drinker
6.529600E-01
Weekly Drinker-vs-Social Drinker
4.917600E-01
Occasional Drinker-vs-Social Drinker
6.910000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.602800E-01
Normal-vs-Grade 2
7.484000E-01
Normal-vs-Grade 3
7.814800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.065510E-02
Grade 1-vs-Grade 3
3.101600E-03
Grade 1-vs-Grade 4
6.602800E-01
Grade 2-vs-Grade 3
3.015400E-01
Grade 2-vs-Grade 4
7.484000E-01
Grade 3-vs-Grade 4
7.814800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.006000E-01
Normal-vs-NonDiabetic
6.023400E-01
Diabetic-vs-NonDiabetic
5.383400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.466600E-01
Normal-vs-NoPancreatitis
5.669800E-01
Pancreatitis-vs-NoPancreatitis
1.234590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.199800E-01
Normal-vs-N1
6.545200E-01
N0-vs-N1
8.341600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.529800E-01
Normal-vs-TP53-NonMutant
7.506000E-01
TP53-Mutant-vs-TP53-NonMutant
7.595900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
